Biomedical Innovative Technology Inc is categorized under Health Services in Marblehead, MA and active since 2009.
Biomedical Innovative Technology Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact C Robert Valeri at the company’s single location by writing to 372 Ocean Avenue, Marblehead, Massachusetts MA 01945 or by phoning (781) 639-0586. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Biomedical Innovative Technology Inc |
Contact Person: | C Robert Valeri |
Address: | 372 Ocean Avenue, Marblehead, Massachusetts 01945 |
Phone Number: | (781) 639-0586 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Health Services |
SIC Code: | 8099 |
NAICS Code: | 621999 |
Share This Business: |
Biomedical Innovative Technology Inc was started in 2009 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact C Robert Valeri for inquiries that concern Biomedical Innovative Technology Inc by calling the company number (781) 639-0586, as your correspondence is most welcome. Additionally, the physical location of the single location of Biomedical Innovative Technology Inc can be found at the coordinates 42.499913,-70.835325 as well as the street address 372 Ocean Avenue in Marblehead, Massachusetts 01945.
For its online presence, you may visit Biomedical Innovative Technology Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.